Emergent BioSolutions Inc expected to post earnings of 11 cents a share - Earnings Preview
Emergent BioSolutions Inc <EBS.N> expected to post earnings of 11 cents a share - Earnings Preview
Emergent BioSolutions Inc EBS.N, EBS is expected to show a rise in quarterly revenue when it reports results on August 5 for the period ending June 30 2026
The Gaithersburg Maryland-based company is expected to report a 26.0% increase in revenue to $177.5 million from $140.9 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.The company's guidance on April 30 2026, for the period ended June 30, was for revenue between $170.00 million and $185.00 million. (Sales/Revenue majority basis is on Total Revenue.)
LSEG's mean analyst estimate for Emergent BioSolutions Inc is for earnings of 11 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Emergent BioSolutions Inc is $12.00, about 61.9% above its last closing price of $7.41
This summary was machine generated August 3 at 21:58 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)